On-Demand Webinar

Drugs to Watch 2019 – The year of the blockbuster

 

  • Dr. Rahul Pandey
    Solution Consultant, Southeast Asia, Clarivate Analytics

Seven drugs are set to enter the market in 2019 and achieve blockbuster status by 2023. Therapies targeting diseases characterized by genetic disorder and/or excessive immune response (including autoimmunity) dominate the list, with six agents out of the seven, and a strong showing by orphan drugs and breakthrough treatments, as well.

Complete the form below to view Drugs to Watch 2019 - The year of the blockbuster.